FOR IMMEDIATE RELEASE: 07/28/2022
The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to advancing the prevention, early diagnosis, and successful treatment of life-threatening blood clots, announced the launch of its new Council for Emerging Researchers in Thrombosis (CERT). CERT will provide a platform for collaboration among early career clinicians and researchers working in the field of thrombosis and thrombophilia with aims to promote and execute research and scientific endeavors on behalf of thrombosis patients.
“CERT heralds in a new day of collaboration on research projects and clinical trials between thrombosis patients and clinicians which should be the model for all research efforts going forward. Additionally, CERT is the foundation for educating clinicians early in their career to ensure they have the tools necessary to identify and treat thrombosis. The CERT members will play a critical role in educating other early-stage clinicians so we can finally close the gap on the lack of thrombosis knowledge that currently exists in this country,” says NBCA Board Chair, Teresa Bordeaux.
According to CERT Co-Chairs Dr. Rushad Patell, a hematologist at Beth Israel Deaconess Medical Center with a research focus on thrombosis and hemostasis and Assistant Professor of Medicine, Harvard Medical School and Dr. Dana Angelini, a Cleveland Clinic hematologist, and Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, who also has a research interest in the field of thrombosis, “NBCA CERT is the first organization of its kind combining the work of both clinicians and patients to improve patient outcomes and, knowing that certain populations such as maternal health and Black Americans have worse thrombotic outcomes, CERT will place a high priority in making sure all populations are equally served and that diversity and inclusion are the building blocks of the work we will do on behalf of the patient community.”
In addition to CERT’s Co-Chairs Drs. Patell and Angelini, founding CERT members include: Shruti Chaturvedi, Johns Hopkins University School of Medicine; Alejandra Gutierrez Bernal, University of Minnesota; Ang Li, Baylor College of Medicine; Kira MacDougall, University of Oklahoma Health Sciences Center; Anjlee Mahajan, UC Davis School of Medicine; Jori E. May, University of Alabama at Birmingham; Anna Parks, University of Utah; and Jordan Schaefer, University of Michigan Health System.
About the National Blood Clot Alliance
The National Blood Clot Alliance is the nation’s leading nonprofit voluntary health organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots such as deep vein thrombosis and pulmonary embolism. Each year NBCA serves more than 3 million people seeking information about blood clots.
For more information about NBCA or CERT, please contact firstname.lastname@example.org or visit www.stoptheclot.org.